Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer

Clinical trial NCT03396926 · COMPLETED

Trial details

NCT number: NCT03396926
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Microsatellite Stable Mismatch Repair Protein Proficient Stage III Colorectal Cancer AJCC v7 Stage IIIB Colorectal Cancer AJCC v7 Stage IIIC Colorectal Cancer AJCC v7 Stage IV Colorectal Cancer AJCC v7 Stage IVA Colorectal Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7

Start date: 2018-04-18
Primary completion: 2024-01-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.